ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $573,000 | +277.0% | 35,044 | +224.9% | 0.04% | +400.0% |
| Q2 2022 | $152,000 | -87.8% | 10,786 | -79.1% | 0.01% | -90.0% |
| Q1 2022 | $1,248,000 | +207.4% | 51,546 | +196.2% | 0.07% | +366.7% |
| Q4 2021 | $406,000 | -63.4% | 17,403 | -73.9% | 0.02% | -73.7% |
| Q3 2021 | $1,108,000 | -17.1% | 66,679 | +21.7% | 0.06% | 0.0% |
| Q2 2021 | $1,337,000 | +25.8% | 54,805 | +33.0% | 0.06% | -3.4% |
| Q1 2021 | $1,063,000 | +115.2% | 41,204 | +345.7% | 0.06% | +43.9% |
| Q4 2020 | $494,000 | +63.6% | 9,244 | +48.3% | 0.04% | -18.0% |
| Q2 2020 | $302,000 | -69.0% | 6,233 | -73.0% | 0.05% | -57.6% |
| Q1 2020 | $975,000 | +114.3% | 23,071 | +116.8% | 0.12% | +218.9% |
| Q4 2019 | $455,000 | +64.3% | 10,641 | +38.3% | 0.04% | +117.6% |
| Q3 2019 | $277,000 | – | 7,696 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |